Gwo Xi Stem Cell Applied Technology Co (ROCO:6704) Capex-to-Revenue : 0.08 (As of Dec. 2024)

Gwo Xi Stem Cell Applied Technology Co Capex-to-Revenue Chart

Gwo Xi Stem Cell Applied Technology Co Semi-Annual Data
	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Capex-to-Revenue	Get a 7-Day Free Trial									0.12	-	-	0.20	0.08

Competitive Comparison of Gwo Xi Stem Cell Applied Technology Co's Capex-to-Revenue

For the Biotechnology subindustry, Gwo Xi Stem Cell Applied Technology Co's Capex-to-Revenue, along with its competitors' market caps and Capex-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Gwo Xi Stem Cell Applied Technology Co's Capex-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Gwo Xi Stem Cell Applied Technology Co's Capex-to-Revenue distribution charts can be found below:

* The bar in red indicates where Gwo Xi Stem Cell Applied Technology Co's Capex-to-Revenue falls into.

Gwo Xi Stem Cell Applied Technology Co Capex-to-Revenue Calculation

Gwo Xi Stem Cell Applied Technology Co's Capex-to-Revenue for the fiscal year that ended in Dec. 2024 is calculated as

Gwo Xi Stem Cell Applied Technology Co's Capex-to-Revenue for the quarter that ended in Dec. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Gwo Xi Stem Cell Applied Technology Co  (ROCO:6704) Capex-to-Revenue Explanation

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue. The ratio shows how aggressively the company reinvests its revenue back into productive assets. However, a high ratio potentially indicates that the company has invested too much in innovation and infrastructure, taking up funds that could be used to boost productivity and increase revenue. Therefore, a high Capex to Revenue Ratio could be a positive or a negative sign depending on how effectively a company converts those investments into future earnings.

Gwo Xi Stem Cell Applied Technology Co Capex-to-Revenue Related Terms

Thank you for viewing the detailed overview of Gwo Xi Stem Cell Applied Technology Co's Capex-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Gwo Xi Stem Cell Applied Technology Co Business Description